Microplastic in human body – a critical insight into current microplastic research
Authors:
M. Vykypělová; V. Khrapova; O. Adamovský
Authors‘ workplace:
RECETOX, PřF MU, Brno
Published in:
Klin Onkol 2026; 39(Supplementum 1): 58-62
Category:
Review
doi:
https://doi.org/10.48095/ccko2026S58
Overview
Background: Microplastics and nanoplastics are ubiquitous environmental contaminants, and human exposure via ingestion and inhalation is increasingly recognized. Numerous studies report microplastics in human tissues and biological fluids, yet the biological relevance and robustness of these findings remain uncertain. This critical work evaluates current evidence on microplastics in the human body, focusing on exposure pathways, particle size relevance, and analytical limitations. Mechanistic data indicate that translocation across intestinal and pulmonary barriers is likely restricted to small microplastics (< 10 µm) and nanoplastics, raising questions about reports of larger particles in human tissues. Key challenges include secondary contamination, size-dependent detection limits, and methodological artifacts associated with common analytical techniques. Experimental evidence for biological effects, including inflammation, microbiome disruption, and cancer-related pathways, is discussed in the context of physiological relevance. Aim: Overall, our work highlights the need for standardized analytical methods, rigorous quality control, and mechanistic studies using realistic exposure scenarios to support sound microplastics related human health research.
Keywords:
health – microplastics – additives – analytical determination – secondary contamination – biologic activity
Sources
1. Monclús L, Arp HP, Groh KJ et al. Mapping the chemical complexity of plastics. Nature 2025; 643 (8071): 349–355. doi: 10.1038/s41586-025-09184-8.
2. Da Costa Filho PA, Andrey D, Eriksen B et al. Detection and characterization of small-sized microplastics (≥ 5 µm) in milk products. Sci Rep 2021; 11 (1): 24046. doi: 10.1038/s41598-021-03458-7.
3. Mohamed Nor NH, Kooi M, Diepens NJ et al. Lifetime accumulation of microplastic in children and adults. Environ Sci Technol 2021; 55 (8): 5084–5096. doi: 10.1021/acs.est.0c07384.
4. Barboza LG, Dick Vethaak A, Lavorante BR et al. Marine microplastic debris: an emerging issue for food security, food safety and human health. Mar Pollut Bull 2018; 133 : 336–348. doi: 10.1016/j.marpolbul.2018.05.047.
5. Xu JL, Wright S, Rauert C et al. Are microplastics bad for your health? More rigorous science is needed. Nature 2025; 639 (8054): 300–302. doi: 10.1038/d41586-025-00702-2.
6. Paul MB, Stock V, Cara-Carmona J et al. Micro - and nanoplastics – current state of knowledge with the focus on oral uptake and toxicity. Nanoscale Adv 2020; 2 (10): 4350–4367. doi: 10.1039/d0na00539h.
7. Nakane H. Translocation of particles deposited in the respiratory system: a systematic review and statistical analysis. Environ Health Prev Med 2012; 17 (4): 263–274. doi: 10.1007/s12199-011-0252-8.
8. Khrapova V. Mikroplasty – mapování jejich efektů na lidi. [online]. Dostupné z: https: //is.muni.cz/th/ay554/2_Khrapova_Final_Project.pdf.
9. Malafaia G, Barceló D. Microplastics in human samples: recent advances, hot-spots, and analytical challenges. TrAC Trends Anal Chem 2023; 161 : 117016.
10. Jones NR, de Jersey AM, Lavers JL et al. Identifying laboratory sources of microplastic and nanoplastic contamination from the air, water, and consumables. J Hazard Mater 2024; 465 : 133276.
11. Leonard VL, Liddle CR, Atherall CA et al. Microplastics in human blood: polymer types, concentrations and characterisation using μFTIR. Environ Int 2024; 188 : 108751. doi: 10.1016/j.envint.2024.
12. Codrington J, Varnum AA, Hildebrandt L et al. Detection of microplastics in the human penis. Int J Impot Res 2024; 37 (5): 377–383. doi: 10.1038/s41443-024-00930-6.
13. Rauert C, Pan Y, Okoffo ED et al. Extraction and pyrolysis-GC-MS analysis of polyethylene in samples with medium to high lipid content. J Environ Expo Assess 2022; 1 (2): 13. doi: 10.20517/jeea.2022.04.
14. Fournier SB, D’Errico JN, Adler DS et al. Nanopolystyrene translocation and fetal deposition after acute lung exposure during late-stage pregnancy. Part Fibre Toxicol 2020; 17 (1): 55. doi: 10.1186/s12989-020-00385-9.
15. Parobková V, Maleček L, Zemek M et al. Advancing microplastic detection in zebrafish with micro computed tomography: A novel approach to revealing microplastic distribution in organisms. J Hazard Mater 2025; 488 : 137442. doi: 10.1016/j.jhazmat.2025.137442.
16. Chen G, Shan H, Xiong S et al. Polystyrene nanoparticle exposure accelerates ovarian cancer development in mice by altering the tumor microenvironment. Sci Total Environ 2024; 906 : 167592. doi: 10.1016/j.scitotenv.2023.
17. Dzierżyński E, Gawlik PJ, Puźniak D et al. Microplastics in the human body: exposure, detection, and risk of carcinogenesis: a state-of-the-art review. Cancers (Basel) 2024; 16 (21): 3703. doi: 10.3390/cancers16213703.
18. Park JH, Hong S, Kim OH et al. Polypropylene microplastics promote metastatic features in human breast cancer. Sci Rep 2023 : 13 (1): 6252. doi: 10.1038/s41598-023-33393-8.
19. Santos AL, Rodrigues CC, Oliveira M et al. Microbiome: a forgotten target of environmental micro (nano) plastics? Sci Total Environ 2022; 822 : 153628. doi: 10.1016/j.scitotenv.2022.153628.
20. Fournier E, Etienne-Mesmin L, Grootaert C et al. Microplastics in the human digestive environment: a focus on the potential and challenges facing in vitro gut model development. J Hazard Mater 2021; 415 : 125632. doi: 10.1016/j.jhazmat.2021.125632.
21. World Health Organization. Microplastics in drinking water. [online]. Available fom: https: //cdn.who.int/media/docs/default-source/wash-documents/microplastics-in-dw-information-sheet190822.pdf.
22. Adamovsky O, Buerger AN, Vespalcova H et al. Evaluation of microbiome-host relationships in the zebrafish gastrointestinal system reveals adaptive immunity is a target of bis (2-ethylhexyl) phthalate (DEHP) exposure. Environ Sci Technol 2020; 54 (9): 5719–5728. doi: 10.1021/acs.est.0c00628.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue Supplementum 1
-
All articles in this issue
- Editorial
- Cancer screening programmes in the Czech Republic and their results
- Polygenic risk score and its role in cancer susceptibility
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- Physical activity in cancer prevention
- Nicotine products on the market and cancer risk
- Impact of obesity on the development of malignant tumors – metabolic syndrome
- Mental health and sleep in cancer prevention – removing barriers to health
- Environmental exposure and cancer prevention in the Czech Republic
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Disruption of hormonal balance and the potential development of cancer – the impact of endocrine disruptors
- Microplastic in human body – a critical insight into current microplastic research
- Microbiome in early cancer detection – biomarker potential and limitations
- Probiotics, postbiotics, and synbiotics in the prevention of oncological diseases
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Cancer screening programmes in the Czech Republic and their results
- Editorial